Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of URGN will decline by -10.35% over the next 2 Weeks and hit $20.44 by Friday, January 2, 2026. In that time frame, URGN's share price is expected to range between $18.69 and $22.28.
BearishAverageBullishURGN shares rose +4.21% in Monday, December 22, 2025's trading session, rising from a previous close of $22.80 to move at $23.76. The stock demonstrated notable intraday movement (see URGN's key stats for a full breakdown), fluctuating between $22.79 and $24.04, a +5.51% trading range. While recent weeks have seen some volatility, URGN has managed to secure a +3.39% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 505.28K shares changing hands, 194.6K fewer than the previous session. This amounted to $12.01M in total market activity.
Will URGN Continue Its Downward Trend?
According to analyst ratings and projections for URGN, UroGen Pharma Ltd. shares are anticipated to decrease by -7.32%, potentially reaching $22.14 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for URGN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the URGN stock forecast, now is not the best time to buy URGN stock because its current trading price is +16.25% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on URGN covering social and institutional perspectives.
URGN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into URGN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 52.33% to 53.36%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 54.78%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.89%, maintains a neutral outlook for the long term. Insights into URGN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
UroGen Pharma Short-Term Forecasts
URGN Forecast For Next 5 Days
Our algorithm anticipates UroGen Pharma (URGN) stock could hit $24.26 by Dec 29, 2025. This represents a +2.09% rise from today's price, following a +1.97% change over the past five days.
URGN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for UroGen Pharma Ltd. (URGN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $23.22, which would mean a -2.27% decrease from the current price of $23.76. Projections for this period range from a high of $29.76 to a low of $18.82.
URGN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for UroGen Pharma's price over the next three months point to a drop. URGN stock is expected to peak at $26.04 on Jan 19, 2026 after potentially dipping to $20.83 on Dec 25, 2025. On average, URGN is likely to trade around $23.61 in the coming 90 days.
UroGen Pharma Stock Forecast 2025
Based on our predictive models, UroGen Pharma (URGN) is expected to trade between $20.83 and $24.23 throughout 2025. This would result in an average price of $22.39, potentially offering investors a -5.77% return from current levels.
UroGen Pharma Ltd. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, UroGen Pharma Ltd. (URGN) is positioned to show a strong performance in December 2025. The price is predicted to move between $20.83 and $24.23, settling at an average of $22.39. This could translate to a -5.77% loss.
January 2026
Based on current market signals, UroGen Pharma Ltd. is projected to trend january 2026. We forecast a trading range from $21.10 to $26.04, with a likely average price of $23.64. Investors could expect a potential return of -0.51%.
February 2026
Our predictive algorithms indicate UroGen Pharma Ltd. stock may see a shift in February 2026. The expected range spans $22.32–$25.92, with an average target of $24.10. This represents a positive outlook and a possible gain of +1.43%.
March 2026
Analyzing established trends, UroGen Pharma Ltd. looks set to move in March 2026. Projections place the stock between $21.33 and $25.51, averaging around $23.43. This suggests a -1.39% loss from current levels.
April 2026
Market indicators suggest UroGen Pharma Ltd. could experience notable changes during April 2026. Prices could fluctuate within $21.46 to $25.56, with a midpoint forecast of $23.62. The stock might deliver a -0.59% loss.
May 2026
Forecasting for May 2026, models estimate that UroGen Pharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $21.71 and $25.45, averaging $23.52. This signals a cautious trajectory with potential returns around -1.01%.
June 2026
According to our latest forecast models, UroGen Pharma Ltd. (URGN) is positioned to show a strong performance in June 2026. The price is predicted to move between $21.90 and $26.88, settling at an average of $24.44. This could translate to a +2.86% gain.
July 2026
Based on current market signals, UroGen Pharma Ltd. is projected to trend july 2026. We forecast a trading range from $22.97 to $26.83, with a likely average price of $24.89. Investors could expect a potential return of +4.76%.
August 2026
Our predictive algorithms indicate UroGen Pharma Ltd. stock may see a shift in August 2026. The expected range spans $22.12–$26.14, with an average target of $24.12. This represents a positive outlook and a possible gain of +1.52%.
September 2026
Analyzing established trends, UroGen Pharma Ltd. looks set to move in September 2026. Projections place the stock between $22.25 and $26.50, averaging around $24.50. This suggests a +3.11% gain from current levels.
October 2026
Market indicators suggest UroGen Pharma Ltd. could experience notable changes during October 2026. Prices could fluctuate within $22.36 to $26.14, with a midpoint forecast of $24.29. The stock might deliver a +2.23% gain.
November 2026
Forecasting for November 2026, models estimate that UroGen Pharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $22.77 and $28.37, averaging $25.49. This signals a positive trajectory with potential returns around +7.28%.
December 2026
According to our latest forecast models, UroGen Pharma Ltd. (URGN) is positioned to show a strong performance in December 2026. The price is predicted to move between $24.13 and $27.43, settling at an average of $25.77. This could translate to a +8.46% gain.
URGN's history of dividends and stock splits also plays a role in long-term investor confidence.